About Hoynoza
Hoynoza is a company. The company has 1 employees as of April 07, 2024. Hoynoza offers products and services including Biosimilar Development and Cell and Gene Therapy.
- Employees 1 as on 07 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Hoynoza Pvt Ltd
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1
as on Apr 07, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hoynoza
Hoynoza offers a comprehensive portfolio of products and services, including Biosimilar Development and Cell and Gene Therapy.
Biosimilar development is conducted by Hoynoza for transformative healthcare solutions.
Cell and gene therapy, including stem cell and viral vector technologies, are pioneered by Hoynoza for medical applications.
Funding Insights of Hoynoza
Detailed funding history for Hoynoza
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hoynoza
Investment portfolio details for Hoynoza
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Hoynoza
Detailed financials for Hoynoza
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hoynoza Comparisons
Peer comparison for Hoynoza
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Hoynoza
Detailed competitors of Hoynoza
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hoynoza
Complete news archive for Hoynoza
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hoynoza
As of Apr 07, 2024, the latest employee count at Hoynoza is 1.
Innovations in biotechnology and medical science are led by Hoynoza, where new ideas are blended with care to navigate healthcare transformation across various disciplines. Groundbreaking solutions in biosimilar development, cell and gene therapy, exosomes, and bio-organoids are undertaken, focusing on patient-centric approaches. Services for biopharmaceutical companies and research institutions are provided, ensuring quality and ethical advancements in monoclonal antibodies and diagnostic kits. A future where healthcare is revolutionized is envisioned by Hoynoza, with expertise in plasmid and organoid technologies.
Hoynoza offers Biosimilar Development and Cell and Gene Therapy.